Showing results (81-90 of 1,766) with videos related to

Sort By:
Pageof 177
JAMA Neurology|November 15, 2016
Female- and Male-Specific Risk Factors for Stroke: A Systematic Review and Meta-analysisMichiel H F Poorthuis, Annemijn M Algra, Ale Algra, et al.
JAMA Neurology|November 15, 2016
A 63-Year-Old Man With Progressive Visual SymptomsSara B Mitchell, Diane Lucente, Mykol Larvie, et al.
JAMA Neurology|February 7, 2017
Neurological Autoantibody Prevalence in Epilepsy of Unknown EtiologyDivyanshu Dubey, Abdulradha Alqallaf, Ryan Hays, et al.
JAMA Neurology|January 24, 2017
Assessment of Early Evidence of Multiple Sclerosis in a Prospective Study of Asymptomatic High-Risk Family MembersZongqi Xia, Sonya U Steele, Anshika Bakshi, et al.
JAMA Neurology|January 24, 2017
Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis SeverityKeren Regev, Brian C Healy, Fariha Khalid, et al.
JAMA Neurology|February 14, 2017
Clinical Evidence of Disease Anticipation in Families Segregating a C9orf72 Repeat ExpansionSara Van Mossevelde, Julie van der Zee, Ilse Gijselinck, et al.
JAMA Neurology|April 7, 2017
Intractable Epilepsy and Progressive Cognitive Decline in a Young ManAlexander L Cohen, Lyell K Jones, Joseph E Parisi, et al.
JAMA Neurology|April 7, 2017
Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral SclerosisChristian Lunetta, Andrea Lizio, Eleonora Maestri, et al.
JAMA Neurology|May 3, 2016
Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod TreatmentStacy Ellen Hatcher, Emmanuelle Waubant, Bardia Nourbakhsh, et al.
JAMA Neurology|May 3, 2016
Genomics of Alzheimer Disease: A ReviewRoger N Rosenberg, Doris Lambracht-Washington, Gang Yu, et al.
Pageof 177